FIELD: medicine.
SUBSTANCE: problem is solved by prescribing patients a preparation of a 1% alcoholic gel of testosterone in the period from 12 to 15 o'clock in a dose of 0.5 ml once a day transdermally for 3 months. The new about the presented method is using testosterone in a dose of 0.5 ml in the period from 12 to 15 o'clock.
EFFECT: reducing a hormone load on the patient's body with preserving the required therapeutic effect.
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING EFFECTIVENESS OF DOSE OF DIETARY SUPPLEMENT LIGNARIUS IN PATIENTS WITH FIBROCYSTIC MASTOPATHY | 2022 |
|
RU2806529C1 |
METHOD OF TREATING CYSTIC FIBROSIS OF BREAST IN FEMALES OF REPRODUCTIVE AGE | 2011 |
|
RU2456010C1 |
METHOD OF TREATING DIFFUSE BENIGN BREAST DYSPLASIA | 2018 |
|
RU2702010C1 |
METHOD OF TREATING MASTOPATHY | 2023 |
|
RU2819077C1 |
METHOD OF TREATING VEGETATIVE DYSFUNCTION ACCOMPANYING DIFFUSE CYSTIC FIBROSIS OF BREAST IN FEMALES OF REPRODUCTIVE AGE | 2011 |
|
RU2471494C2 |
METHOD OF TREATING CYSTIC FIBROSIS OF BREAST IN FEMALES OF REPRODUCTIVE AGE | 2011 |
|
RU2456009C1 |
METHOD FOR PREDICTION OF DEVELOPING COMPLICATIONS IN WOMEN SUFFERING CLIMACTERIC SYNDROME AND MASTOPATHY AND EMPLOYING HORMON REPLACEMENT | 2010 |
|
RU2426994C1 |
METHOD FOR TREATING MASTOPATHY | 2002 |
|
RU2226400C1 |
BREAST CYST FORMATIONS CLASSIFICATION | 2017 |
|
RU2639804C1 |
METHOD FOR TREATMENT OF MASTOPATHY | 2003 |
|
RU2233669C1 |
Authors
Dates
2015-04-20—Published
2013-12-10—Filed